Mark Stejbach, SVP/Chief Comm Off, Alks Inc at Alkermes, holds 0.00 shares in Flexion Therapeutics (Ticker: FLXN), holds 51.06K shares in Alkermes (Ticker: ALKS).
What is the percentage of profitable transactions made by Mark Stejbach?
The percentage of profitable transactions made by Mark Stejbach is 67%.
What is the average return per transaction made by Mark Stejbach?
The average return per transaction made by Mark Stejbach is 26.80%.
What stocks does Mark Stejbach hold?
Mark Stejbach holds: ALKS, FLXN stocks.
What was Mark Stejbach’s latest transaction?
Mark Stejbach latest transaction was an Uninformative Sell of $107.36K.
What was Mark Stejbach's most profitable transaction?
Mark Stejbach’s most profitable transaction was an Informative Buy of FLXN stock on June 20, 2017. The return on the trade was 55.60%.
What is Mark Stejbach's role in Alkermes?
Mark Stejbach's role in Alkermes is SVP/Chief Comm Off, Alks Inc.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.